Society of Gynecologic Oncologists Clinical Practice Committee statement on prophylactic salpingo-oophorectomy

被引：30

作者：

不详

机构：

来源：

GYNECOLOGIC ONCOLOGY | 2005年 / 98卷 / 02期

关键词：

D O I：

10.1016/j.ygyno.2005.05.002

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

收藏

页码：179 / 181

页数：3

相关论文

共 16 条

[1] A genetic epidemiological study of carcinoma of the fallopian tube [J].

Aziz, S ;

Kuperstein, G ;

Rosen, B ;

Cole, D ;

Nedelcu, R ;

McLaughlin, J ;

Narod, SA .

GYNECOLOGIC ONCOLOGY, 2001, 80 (03) :341-345

[2] Peritoneal lavage cytology: An assessment of its value during prophylactic oophorectomy [J].

Colgan, TJ ;

Boerner, SL ;

Murphy, J ;

Cole, DEC ;

Narod, S ;

Rosen, B .

GYNECOLOGIC ONCOLOGY, 2002, 85 (03) :397-403

[3] Occult carcinoma in prophylactic oophorectomy specimens - Prevalence and association with BRCA germline mutation status [J].

Colgan, TJ ;

Murphy, J ;

Cole, DEC ;

Narod, S ;

Rosen, B .

AMERICAN JOURNAL OF SURGICAL PATHOLOGY, 2001, 25 (10) :1283-1289

[4] Genetic heterogeneity and penetrance analysis of the BRCA1 and BRCA2 genes in breast cancer families [J].

Ford, D ;

Easton, DF ;

Stratton, M ;

Narod, S ;

Goldgar, D ;

Devilee, P ;

Bishop, DT ;

Weber, B ;

Lenoir, G ;

Chang-Claude, J ;

Sobol, H ;

Teare, MD ;

Struewing, J ;

Arason, A ;

Scherneck, S ;

Peto, J ;

Rebbeck, TR ;

Tonin, P ;

Neuhausen, S ;

Barkardottir, R ;

Eyfjord, J ;

Lynch, H ;

Ponder, BAJ ;

Gayther, SA ;

Birch, JM ;

Lindblom, A ;

Stoppa-Lyonnet, D ;

Bignon, Y ;

Borg, A ;

Hamann, U ;

Haites, N ;

Scott, RJ ;

Maugard, CM ;

Vasen, H .

AMERICAN JOURNAL OF HUMAN GENETICS, 1998, 62 (03) :676-689

[5] Defining cancer risks for BRCA germline mutation carriers:: implications for surgical prophylaxis [J].

Karlan, BY .

GYNECOLOGIC ONCOLOGY, 2004, 92 (02) :519-520

[6] Risk-reducing salpingo-oophorectomy in women with a BRCA1 or BRCA2 mutation. [J].

Kauff, ND ;

Satagopan, JM ;

Robson, ME ;

Scheuer, L ;

Hensley, M ;

Hudis, CA ;

Ellis, NA ;

Boyd, J ;

Borgen, PI ;

Barakat, RR ;

Norton, L ;

Offit, K .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (21) :1609-1615

[7] Breast and ovarian cancer risks due to inherited mutations in BRCA1 and BRCA2 [J].

King, MC ;

Marks, JH ;

Mandell, JB .

SCIENCE, 2003, 302 (5645) :643-646

[8] BRCA germline mutations in Jewish women with uterine serous papillary carcinoma [J].

Lavie, O ;

Hornreich, G ;

Ben-Arie, A ;

Rennert, G ;

Cohen, Y ;

Keidar, R ;

Sagi, S ;

Lahad, EL ;

Auslander, R ;

Beller, U .

GYNECOLOGIC ONCOLOGY, 2004, 92 (02) :521-524

[9] Occult ovarian tumors in women with BRCA1 or BRCA2 mutations undergoing prophylactic oophorectomy [J].

Lu, KH ;

Garber, JE ;

Cramer, DW ;

Welch, WR ;

Niloff, J ;

Schrag, D ;

Berkowitz, RS ;

Muto, MG .

JOURNAL OF CLINICAL ONCOLOGY, 2000, 18 (14) :2728-2732

[10] Risk-reducing salpingo-oophorectomy in BRCA mutation carriers:: Role of serial sectioning in the detection of occult malignancy [J].

Powell, CB ;

Kenley, E ;

Chen, LM ;

Crawford, B ;

McLennan, J ;

Zaloudek, C ;

Komaromy, M ;

Beattie, M ;

Ziegler, J .

JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (01) :127-132